PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu.\', \'Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu.\', \'Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Division of Pulmonology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\', \'Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lbrando@jhmi.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s42003-022-03189-z
?:doi
?:hasPublicationType
?:journal
  • Communications biology
is ?:pmid of
?:pmid
?:pmid
  • 35304580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all